BXP
44
6
YUM
61
-2
PM
60
-2
COP
22
3
PEG
46
3
HUM
35
-4
QCOM
55
5
R
62
-4
HCA
55
4
AAP
17
5
RIG
16
9
OI
43
2
CINF
38
-5
VMC
53
-6
BA
24
-2
SE
77
-3
HST
39
5
MCO
59
-5
MMM
49
2
LNC
45
2
BXP
44
6
YUM
61
-2
PM
60
-2
COP
22
3
PEG
46
3
HUM
35
-4
QCOM
55
5
R
62
-4
HCA
55
4
AAP
17
5
RIG
16
9
OI
43
2
CINF
38
-5
VMC
53
-6
BA
24
-2
SE
77
-3
HST
39
5
MCO
59
-5
MMM
49
2
LNC
45
2
Financhill
Back

Akero Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
17

AKRO
Akero Therapeutics

Last Price:
$41.69
Seasonality Move:
-20.18%
Sell
35

NBY
NovaBay Pharmaceuticals

Last Price:
$0.58
Seasonality Move:
-8.46%
Sell
17
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $42.10. The Score for AKRO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.60. The Score for NBY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $42.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 40.45 Sell
Chaikin Money Flow: -857514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.09 - 54.09) Sell
Bollinger Bands (100): (25.41 - 45.17) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.37 Sell
Chaikin Money Flow: 39547 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.67) Sell
Bollinger Bands (100): (0.57 - 0.71) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.7 Sell
20-day SMA: 48.75 Sell
50-day SMA: 39.78 Buy
200-day SMA: 30.05 Buy
8-day EMA: 45.32 Sell
20-day EMA: 46.41 Sell
50-day EMA: 42.22 Sell
200-day EMA: 33.02 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Sell
20-day SMA: 0.64 Sell
50-day SMA: 0.65 Sell
200-day SMA: 1.16 Sell
8-day EMA: 0.6 Sell
20-day EMA: 0.63 Sell
50-day EMA: 0.64 Sell
200-day EMA: 3.13 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.63 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):